MXPA05012696A - Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica. - Google Patents
Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica.Info
- Publication number
- MXPA05012696A MXPA05012696A MXPA05012696A MXPA05012696A MXPA05012696A MX PA05012696 A MXPA05012696 A MX PA05012696A MX PA05012696 A MXPA05012696 A MX PA05012696A MX PA05012696 A MXPA05012696 A MX PA05012696A MX PA05012696 A MXPA05012696 A MX PA05012696A
- Authority
- MX
- Mexico
- Prior art keywords
- formulations
- inflammatory agents
- steroidal anti
- ocular angiogenesis
- pathologic ocular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47825203P | 2003-06-13 | 2003-06-13 | |
| US47822703P | 2003-06-13 | 2003-06-13 | |
| PCT/US2004/018792 WO2004112772A1 (en) | 2003-06-13 | 2004-06-14 | Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05012696A true MXPA05012696A (es) | 2006-02-22 |
Family
ID=33544369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05012696A MXPA05012696A (es) | 2003-06-13 | 2004-06-14 | Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070043006A1 (https=) |
| EP (1) | EP1633339A4 (https=) |
| JP (1) | JP2007500250A (https=) |
| KR (1) | KR20060019579A (https=) |
| AU (1) | AU2004249167A1 (https=) |
| BR (1) | BRPI0411427A (https=) |
| CA (1) | CA2527121A1 (https=) |
| MX (1) | MXPA05012696A (https=) |
| RU (1) | RU2006101150A (https=) |
| WO (1) | WO2004112772A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1635842A4 (en) * | 2003-06-20 | 2007-04-04 | Alcon Inc | TREATMENT OF AMD WITH A COMBINATION OF INGREDIENTS |
| TW200812575A (en) * | 2006-04-28 | 2008-03-16 | Alcon Inc | Formulations containing amide derivatives of carboxylic acid NSAIDs for topical administration to the eye |
| ES2667945T3 (es) | 2007-10-08 | 2018-05-16 | Aurinia Pharmaceuticals Inc. | Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR |
| EP2440185B1 (en) * | 2009-06-09 | 2015-04-08 | Aurinia Pharmaceuticals Inc. | Topical drug delivery systems for ophthalmic use |
| WO2014207769A1 (en) | 2013-06-27 | 2014-12-31 | Mylan Laboratories Ltd | Process for the preparation of nepafenac |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4975537A (en) * | 1985-10-23 | 1990-12-04 | The Upjohn Company | Δ9(11) -angiostatic steroids |
| US4771042A (en) * | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
| CA1331559C (en) * | 1986-04-21 | 1994-08-23 | Jon Joseph Kabara | Antimicrobial preservative compositions and methods |
| US4853224A (en) * | 1987-12-22 | 1989-08-01 | Visionex | Biodegradable ocular implants |
| US4910225A (en) * | 1988-01-27 | 1990-03-20 | Senju Pharmaceutical Co., Ltd. | Locally administrable therapeutic composition for inflammatory disease |
| US5164188A (en) * | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
| DE69132048T2 (de) * | 1990-06-11 | 2000-07-13 | Alcon Laboratories Inc.(N.D.Ges.D.Staates Delaware), Forth Worth | Verwendung von Steroiden zur Inhibierung von Angiogenesis |
| US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| US5770592A (en) * | 1991-11-22 | 1998-06-23 | Alcon Laboratories, Inc. | Prevention and treatment of ocular neovascularization using angiostatic steroids |
| US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| AU1970197A (en) * | 1996-05-09 | 1997-11-26 | Alcon Laboratories, Inc. | Use of steroid compounds to prevent non-cancerous tissue growth |
| US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
| CA2383499C (en) * | 1999-10-21 | 2009-11-24 | Alcon Universal Ltd. | Drug delivery device |
| JP2003511204A (ja) * | 1999-10-21 | 2003-03-25 | アルコン，インコーポレイティド | テノン下薬剤送出 |
| US6416777B1 (en) * | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
| AR030346A1 (es) * | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico |
| AU2002247284A1 (en) * | 2001-04-02 | 2002-10-15 | Alcon, Inc. | Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac |
-
2004
- 2004-06-14 US US10/557,133 patent/US20070043006A1/en not_active Abandoned
- 2004-06-14 AU AU2004249167A patent/AU2004249167A1/en not_active Abandoned
- 2004-06-14 WO PCT/US2004/018792 patent/WO2004112772A1/en not_active Ceased
- 2004-06-14 MX MXPA05012696A patent/MXPA05012696A/es not_active Application Discontinuation
- 2004-06-14 CA CA002527121A patent/CA2527121A1/en not_active Abandoned
- 2004-06-14 JP JP2006533771A patent/JP2007500250A/ja not_active Withdrawn
- 2004-06-14 EP EP04755138A patent/EP1633339A4/en not_active Withdrawn
- 2004-06-14 BR BRPI0411427-2A patent/BRPI0411427A/pt not_active IP Right Cessation
- 2004-06-14 US US10/867,289 patent/US20040259765A1/en not_active Abandoned
- 2004-06-14 KR KR1020057023543A patent/KR20060019579A/ko not_active Withdrawn
- 2004-06-14 RU RU2006101150/14A patent/RU2006101150A/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007500250A (ja) | 2007-01-11 |
| RU2006101150A (ru) | 2006-06-10 |
| US20070043006A1 (en) | 2007-02-22 |
| BRPI0411427A (pt) | 2006-07-25 |
| EP1633339A4 (en) | 2009-06-03 |
| CA2527121A1 (en) | 2004-12-29 |
| AU2004249167A1 (en) | 2004-12-29 |
| US20040259765A1 (en) | 2004-12-23 |
| KR20060019579A (ko) | 2006-03-03 |
| EP1633339A1 (en) | 2006-03-15 |
| WO2004112772A1 (en) | 2004-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR052774A1 (es) | Inmunoterapia para trastornos autoinmunes | |
| CL2007002708A1 (es) | Compuestos derivados de pirrolo[2,3-b]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, caquexia, trastornos inflamatorios, entre otros. | |
| EA200870556A1 (ru) | Комбинированная терапия в лечении эпилепсии и родственных расстройств | |
| CR8498A (es) | Derivados de prostaglandinas | |
| UA85559C2 (en) | Aminobenzophenone compounds | |
| HN2005035605A (es) | Analogos de rapamicina y los usos de los mismos en el tratamiento de trastornos neurologicos, proliferativos e inflamatorios | |
| DK1938839T3 (da) | Oftalmiske sammensætninger af parasympatiske stimulanter og anti-inflammatoriske midler til anvendelse i behandlingen af presbyopi | |
| UY28126A1 (es) | Uso de glucocorticoides selectivos para la superficie ocular en el tratamiento de la sequedad ocular | |
| PA8586001A1 (es) | Derivados de indol útiles para el tratamiento de enfermedades | |
| CL2008001813A1 (es) | Compuestos derivados de quinolin-3-carbonitrilo sustituidos con piperazina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis, inflamacion, cancer entre otras (div. sol. 266-04). | |
| NO20073574L (no) | Triazolsubstituerte aminobenzofenonforbindelser | |
| UY28150A1 (es) | Agentes terapeuticos | |
| GT200300294A (es) | Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso | |
| IN2015DN00502A (https=) | ||
| CL2007002207A1 (es) | Compuestos derivados de sulfonilaminas; composicion farmaceutica; y uso de los compuestos en el tratamiento del glaucoma. | |
| ECSP055964A (es) | Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6 | |
| AR056306A1 (es) | FORMA CRISTALINA ORTORRoMBICA DEL MALEATO DE ASENAPINA , COMPOSICIONES FARMACÉUTICAS Y SU USO EN EL TRATAMIENTO DE TRASTORNOS MENTALES | |
| EA200701845A1 (ru) | Рофлумиласт для лечения сахарного диабета | |
| CL2008000495A1 (es) | Compuestos derivados de tetrahidro-pirazolo[4,3-c]piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alergias, inflamacion, dolor, cancer, entreotras. | |
| AR048135A1 (es) | Uso de gen de amiloide a serico en el diagnostico y tratamiento del glaucoma y en la identificacion de agentes anti-glaucoma. | |
| ECSP088250A (es) | Derivados de pirazol como agentes terapéuticos | |
| DE60142913D1 (de) | Arzneilösungen enthaltend modafinilverbindungen | |
| BRPI0407693A (pt) | uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos | |
| UY29802A1 (es) | Análogos de la feniletilamina y su uso en el tratamiento del glaucoma | |
| MXPA05012696A (es) | Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |